简体
  • 简体中文
  • 繁体中文
×

热门资讯> 正文

Entero Therapeutics推出300万美元证券发行

2025-08-11 20:07

  • Entero Therapeutics (NASDAQ:ENTO) signed deals with institutional investors to raise about $3 million through the sale of pre-funded and common stock warrants, priced at market under Nasdaq rules.
  • The offering includes 4.88 million pre-funded warrants and 9.76 million common warrants, with proceeds split—$1 million at closing and $2 million upon effectiveness of a resale registration statement.
  • The combined purchase price for one pre-funded warrant and two common warrants is $0.6149. The pre-funded warrants will be immediately exercisable at an exercise price of $0.00001 and may be exercised at any time until exercised in full
  • Closing is expected around August 11, 2025, with funds to be used for general corporate purposes and working capital.
  • Shares jumped 53% premarket.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
问答大全
（工作日09：30 - 次日05：30）
客户端：
关注我们：
  • 微信公众号二维码

© 2025 深圳市时代华盛网络科技有限公司版权所有 粤ICP备16068286号